Literature DB >> 15804310

A practical approach for the use of oral isotretinoin for infantile acne.

Cheryl J Barnes1, Lawrence F Eichenfield, Jungho Lee, Bari B Cunningham.   

Abstract

Infantile acne is a rare occurrence. It is more common in boys and predominately occurs on the cheeks in infants between the ages of 1 and 16 months. Clinically, the lesions range from comedones to inflammatory papulopustules to cysts. Successful therapies include topical tretinoin, benzoyl peroxide and topical and oral erythromycin. For more serious cases, oral isotretinoin (Accutane) has been reported to successfully treat recalcitrant infantile cystic acne. We describe two additional patients with infantile cystic acne treated successfully with oral isotretinoin. The dose of isotretinoin used ranged from 0.2 mg/kg/day to 1.5 mg/kg/day. The treatment duration varied from 5 to 14 months. Careful monthly monitoring is recommended because of the many side effects reported with isotretinoin. Practical tips for the administration of oral isotretinoin in infants are reviewed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15804310     DOI: 10.1111/j.1525-1470.2005.22224.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  2 in total

1.  [Systemic retinoid therapy in severe acne infantum].

Authors:  M Hütten; J M Baron; H Ott
Journal:  Hautarzt       Date:  2008-06       Impact factor: 0.751

Review 2.  Practical implications for the administration of 13-cis retinoic acid in pediatric oncology.

Authors:  Tiene G M Bauters; Geneviève Laureys; Véronique Van de Velde; Yves Benoit; Hugo Robays
Journal:  Int J Clin Pharm       Date:  2011-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.